Duncan Williams

Duncan Williams has upgraded Rowan Companies (NYSE: RDC) from Sell to Strong Buy and maintains its $54 price target.

Duncan Williams has upgraded its rating on Transocean (NYSE: RIG) from a Reduce to Strong Buy in a research report published today. In the report, Duncan Williams states, “With the stock trading slightly above book value of $67, trading at over a 16 percent discount to the group on a P/E basis for...

Duncan Williams has raised the price target on Western Union (NYSE: WU) from $23 to $24 and maintains its Buy rating.

Duncan Williams is out with its report today on Noble (NYSE: NE), reiterating Reduce. In a note to clients, Duncan Williams writes, "After the close yesterday, Noble released a fleet status with increased downtime on certain rigs, contract slippage, and a fire on one jackup rig, which has removed...

Duncan Williams is out with its report today on Willbros Group (NYSE: WG), initiating coverage on WG at Strong Buy. In a note to clients, Duncan Williams writes, "Our STRONG BUY rating is based on an earnings multiple of 20x 2012 estimated earnings, yielding a target of $16.00 per share. With the...

Duncan Williams has issued a report raising the Price Target on Endo Pharmaceuticals (NASDAQ: ENDP) from $46 to $51 a share. : Duncan Williams writes, “Endo will now have $1 billion in urology sales, providing scale for more efficient manufacturing, procurement, distribution, and pricing...

Duncan Williams has downgraded Helmerich & Payne (NYSE: HP) from Buy to Reduce.

Duncan Williams is raising its price target on shares of Global Payments, Inc. (NYSE: GPN) to $52 from $55, and it has a Buy rating on shares. In a note to clients, Duncan Williams writes, "Global Payments reported F3Q11 results that were ahead of expectations on revenues, but EPS missed our...

Duncan Williams raised its Obagi Medical Products (NASDAQ: OMPI) rating from Hold to Buy and initiated Obagi Medical Product's price target at $14 in a research report. In the report, Duncan Williams states, "Management is investing in PR and social media promotional initiatives to increase...